SEATTLE, WA / ACCESSWIRE / August 19, 2020 / GRN Holding Corporation (OTC PINK:GRNF), (the "Company"), announced today that the Company has entered into a binding letter of intent to acquire Pacific Merchant Processing, Inc. This announcement follows the completion of due diligence earlier this year and will help to define the terms of a mutual definitive agreement to finalize the acquisition.

Pacific Merchant Processing, Inc. (www.pmpcredit.com), located in Bellevue, Washington, specializes in creating merchant partners in the cannabis, hemp and ancillary markets. PMP has added levels of security and accountability allowing it to work with financial networks to provide card processing services to state licensed producers, processors and retail locations. PMP offers a variety of solutions that fit all scales or verticals of business.

Developing long-term relationships with its merchant, processing, and banking partners enables the company to provide almost real-time information and insulate its merchants from any changes in the landscape of payment processing that could affect their business. PMP has accounts in seven states and is expanding to the Midwest and Northeast United States. The acquisition will include all assets, licenses, source code, intellectual property, processing assets, commission, and 100% of equity in the business.

About GRN Holding Corporation

GRN Holding Corporation (OTC Pink:GRNF) is a Nevada registered publicly-traded company.

For more information, please contact:

Justin Costello
IR@grnholding.com

Forward-looking Statements

This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

SOURCE: GRN Holding Corporation

ReleaseID: 602392

CALGARY, AB / ACCESSWIRE / August 19, 2020 / Aurwest Resources Corporation ("Aurwest" or the "Company") (CSE:AWR) is pleased to provide the results of its recently completed compilation of historical and recent exploration data for its 100% owned Stellar Project. This 22,700-hectare property is in west-central British Columbia within the Omineca Mining Division and is approximately 25 km southwest of the town of Houston, BC. The historical exploration data and analytical results reported in this news release with the exception of the airborne geophysical survey completed in 2019, (see News Release dated February 25, 2019) were taken from the numerous assessment reports filed with the department of Mines and Energy for British Columbia over the past 50 years and on BC MINFILES. Neither Aurwest nor a qualified person has verified the historical sampling, analytical, and test data contained in this news release. The historical grab sampling results reported in this news release are selected samples and are not necessarily indicative of the mineralization hosted on the property.

Background

The Stellar property is an early stage exploration project with significant potential to host porphyry copper and structurally controlled gold deposits. The property has been explored intermittently since the late 1960's, and most recently in 2019, when Aurwest completed a 1,049 km airborne geophysical survey over the property. The highlights of this compilation are as follows:

Key Highlights

Four porphyry copper targets have been identified, each exhibiting an aeromagnetic signature suggestive of a porphyry copper system.

The property is underlain by Hazelton Group mafic volcanics intruded by Bulkley intrusives and numerous felsic (some porphyritic) dikes.

Widespread copper-gold-silver mineralization with numerous rock samples containing greater than 1.0% copper, and in some cases molybdenum, occurs within the Lynx target.

The high-grade copper-silver veins in skarn (chalcopyrite-bornite) suggests proximity to a porphyry copper system within the Erin zone.

A 2.4 km long, structurally controlled Quartz vein system is located in the Lynx target, with gold values up to 37.6 g/t (1.2 oz/t).

Colin Christensen, President and CEO of Aurwest, stated, "The compilation and re-interpretation of the exploration data has substantially re-defined the Stellar project geology, and has materially expanded the mineral potential of the property with four porphyry copper and one gold-silver targets for follow-up exploration."

Porphyry Copper Targets

The exploration model being used at Stellar is the Stars discovery, modelled after the Huckleberry copper porphyry deposit/mine located to the south of the Stars project. The Stars discovery is situated on claims that adjoin the Company's southern boundary and occurs in a large (~5km diameter) positive circular magnetic feature. The copper mineralization is hosted in a potassic altered monzodiorite intrusion, and in porphyry dikes which cut the larger intrusion, and in hornfelsed and silicified Hazelton Group volcanics along the volcanic/monzodiorite contact. At Stellar, four under explored targets with magnetic signatures typically associated with a porphyry system have been delineated: Lynx/Erin-Cassiopeia-Orion and Big Dipper. Most of the available historical exploration data covers areas within the Lynx/Erin target. The Orion and Big Dipper targets, located on strike with the Stars discovery, display several Cretaceous stocks and several northwest or northeast trending linear magnetic anomalies, which may reflect porphyritic dikes and stocks. Cassiopeia is a large circular magnetic feature located south of the Lynx/Erin target. A summary of the Lynx/Erin target is set out below:

Lynx: This target is a circular magnetic anomaly like that described at the Stars copper discovery with supporting soil and rock sampling results but limited geophysical surveys and diamond drilling. This target covers an early Cretaceous quartz monzonite stock and contains the Lunlik, Carbonate and Number 51 showings.

The Lunlik Showing – is underlain by a granodiorite with minor chalcopyrite and pyrite. Historical diamond drill logs show intervals of weak chalcopyrite-pyrite mineralization hosted in quartz veins and veinlets with K-spar alteration envelopes in the granodiorite. No analytical results were reported. A historical select grab sample from this showing returned 0.857 g/t Au and 0.0169 % Cu

The Carbonate Showing – is a breccia with abundant secondary copper oxide minerals hosted in a gossan (oxidized pyrite) where historical select grab samples yielded analytical results up to 0.56 % Cu, 17 ppb Au, 11.7 g/t Ag, 0.095 % As and 0.16 % Sb.

The Number 51 Showing – is reported to contain molybdenum mineralization within a porphyry stock intruding Hazelton Group volcanics. Analytical values are not reported.

Erin: This target is located on the west edge of the Lynx target and covers shear-hosted copper-gold-silver mineralization within Hazelton volcanics intruded by a Bulkley Intrusive. Historical exploration consisted of trenching, mapping, and sampling over an area measuring 1500 metres by 700 metres that located copper mineralization in veins and as dissemination in skarn and hornfelsed Hazleton volcanics. Of the 31 historical select grab samples collected, 25 samples assayed greater than 0.1% Cu, and of these, 18 samples assayed greater than 1.0% Cu. A high grade select grab sample collected in 1988 from one trench yielded 43% copper, 11,073 g/t Ag (356 oz/t), and 6.5 g/t Au (0.21 oz/t) . This target area also includes the Del Showing, which consists of disseminated chalcopyrite, bornite, malachite, azurite, and pyrite in Hazelton Group volcanics. Histroical select grab samples assayed from 0.21% to 6.14% Cu and up to 25.3 g/t Ag.

Gold-Silver Target

This target is located within the Lynx Target and covers an area that measures approximately 2,400m by 1,000m and includes the Jewelry Box, Central, Ridge, and East Ridge gold showings. Historical soil sampling surveys have outlined widespread gold-silver in soil geochemical anomalies underlain by silicified volcanics of the Telkwa Formation (Hazelton Group) along three NNE trending faults. These Hazelton Group rocks are intruded by dikes, sills and stocks of granite and monzonite composition. Epidote-quartz-pyrite, silicification and iron carbonate are the main types of alteration within this target.

Jewelry Box: Gold mineralization occurs with disseminations, fracture fillings, bands of pyrite and in quartz-pyrite veins in silicified breccias and silicified pyritized hornfels. Select historical grab sampling of outcrops returned values from 0.35g/t to 37.6 g/t Au, from 2.7g/t to 75.5 g/t Ag and from 150 to 13,000 parts per million ("ppm") (1.3%) Cu. Quartz vein float containing 1,335 ppm Cu and 2,940 ppb (2.94g/t) Au approximately 50m east of the Jewelry Box showing suggests the zone may be more extensive. In 2012 International Samuel drilled two diamond drill holes in the Jewelry Box showing that returned 0.35 m averaging 2.23 g/t Au and 0.3% Cu, 2.6 m grading 0.16% Cu and 0.4 g/t Au and 0.26% Cu over 0.45m. These drilling results have not been verified by Aurwest and do not explain the widespread gold-silver copper mineralization in outcrop and soil geochemical anomalies.

Central: Located between the Jewelry Box and Ridge showings, select rock sampling returned from 0.017g/t to 4.92g/t Au, from 0.2g/t to 133.4 g/t Ag and from 40 to 865 ppm Cu. A historical select grab sample collected approximately 100 m north of the Jewelry Box showing from a quartz-iron-carbonate altered breccia returned 19,960 ppm (1.99%) Cu, 972 ppm arsenic and 2,350 ppb (2.35g/t) Au. This area is within the major NNE structure that hosts the Ridge and Jewelry Box showings.

Ridge: Histroical selected grab samples returned values from 4.2g/t to 18.3g/t Au and from trace to 25.5 g/t Ag.

East Ridge: Located approximately 500m east of the Ridge showing and historical select grab sampling returned 2.6 g/t and 3.02 g/t Au.

Future Plans

In next phase of exploration, Aurwest intends to verify the historical results set out his this news release by focusing on additional mapping to better define the lithologies, alterations and styles of mineralization on the Lynx target, and stream sediment sampling and mapping programs in the vicinity of the Orion, Big Dipper and Cassiopeia targets. Detailed mapping of lithologies and alterations followed by ground geophysical survey are contemplated on the precious metal target.

Figure 3: Stellar Project Airborne Geophysical Survey

Elmer B. Stewart, MSc. P. Geol., a director is the Company's non-independent, nominated Qualified Person pursuant to National Instrument 43-101, Standards for Disclosure for Mineral Projects, and has reviewed and approves the scientific and technical information disclosed in this news release.

On Behalf Of Aurwest resources Corporation

Colin Christensen

President and Chief Executive Officer

For additional information please contact:
Colin Christensen
Telephone: (403) 483-8363
Email: cchristensen@aurwestresources.com

Website: aurwestresources.com

About Aurwest Resources Corporation

Aurwest is a Canadian-based junior mining/exploration company focused on the procurement, exploration and development of gold, silver, and other precious and base metal properties in North America. The Company currently holds a 100% interest in the Stellar copper/gold Project, located approximately 25 kilometers southwest of Houston British Columbia.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information

This news release contains forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and forward-looking information within the meaning of the Canadian securities laws (collectively, "forward-looking information"). Forward-looking information is generally identifiable by use of the words "believes," "may," "plans," "will," "anticipates," "intends," "budgets", "could", "estimates", "expects", "forecasts", "projects" and similar expressions, and the negative of such expressions.

In connection with the forward-looking information contained in this news release, Aurwest Resources and its subsidiaries have made numerous assumptions regarding, among other things: the geological advice that Aurwest Resources has received is reliable and is based upon practices and methodologies which are consistent with industry standards and the reliability of historical reports. While Aurwest Resources considers these assumptions to be reasonable, these assumptions are inherently subject to significant uncertainties and contingencies.

Additionally, there are known and unknown risk factors which could cause Aurwest Resources actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. Known risk factors include, among others: the dimensions and shape of the mineralized areas may not be as estimated; the surface mineralization, alteration and goethite veining may not represent buried porphyry style mineralization; uncertainties relating to interpretation of the outcrop sampling results; the geology, continuity and concentration of the mineralization; the financial markets and the overall economy may deteriorate; the need to obtain additional financing; uncertainty as to timely availability of permits and other governmental approvals.

A more complete discussion of the risks and uncertainties facing Aurwest Resources is disclosed in Aurwest Resources continuous disclosure filings with Canadian securities regulatory authorities at www.sedar.com. All forward-looking information herein is qualified in its entirety by this cautionary statement, and Aurwest disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

SOURCE: Aurwest Resources Corporation

ReleaseID: 602300

TORONTO, ON / ACCESSWIRE / August 19, 2020 / Murchison Minerals Ltd. ("Murchison" or the "Company") (TSXV:MUR) is pleased to announce the acquisition, by online staking, of two additional claim blocks totalling 6,187 hectares north and northeast of the Brabant Lake Project. The new mineral claims, titled the May Lake claim and the Cunning Lake claim, are 100% owned by Murchison Minerals Ltd.

The May Lake claim totalling 1,333 ha is located north of the Brabant Lake Project, 29 km north of Murchison's Brabant-McKenzie copper-zinc-silver deposit and approximately 8 km west of Highway 905. The claim covers a historic Geological Survey of Canada regional lake sediment sample collected from a small lake (Jones Lake) which assayed 780 ppm zinc, which is highly anomalous, 16 ppb Au, 81 ppm copper, and there is no silver assay. The GSC lake sediment sample data covers much of the exposed Precambrian shield in Saskatchewan and this sample is among the highest zinc values obtained in the survey. Limited historic drilling done on the property in 1969 and 1974 encountered strong pyrite and pyrrhotite mineralization which may indicate VMS potential.

The Cunning Lake claim totalling 4,853 ha is located on Highway 102 northeast of the Brabant Lake Project, 29 km north of the Brabant-McKenzie deposit and 5 km west of the community of Southend. The claim overlies the Cunning or Halfway Lake lead occurrence where notable lead sulphide (galena) and copper iron sulphide (chalcopyrite) have been historically identified in outcrop. The mineralization was noted as occurring within a silicified migmatite zone. Galena and chalcopyrite are often associated with volcanogenic massive sulphide (VMS) deposits or orogenic gold deposits and represent a prospective target for exploration. This area has seen limited exploration in 1962 and 1967 with no historic diamond drilling reported.

Murchison Minerals intends to prospect the new claim areas utilizing GDD's beep mat technology. The new claims add to Murchison's considerable claims in the area.

About the Brabant‐McKenzie Project

The Brabant-McKenzie project is located 175 kilometres northeast of La Ronge, Saskatchewan and approximately three kilometres from the community of Brabant Lake. The area is accessed year-round via provincial Highway 102 and is serviced by grid power. The project consists of one mining lease, which hosts the Brabant-McKenzie VMS deposit, and additional mineral claims totalling 627 square kilometres, which cover approximately 57 kilometres of strike length over favourable geological horizons, multiple known mineralized showings and identified geophysical conductors.

Qualifying Statement

The foregoing scientific and technical disclosures have been reviewed by John Shmyr, P. Geo., and Andrew Masurat, P. Geo., qualified persons as defined by National Instrument 43-101. Mr. Shmyr and Mr. Masurat are independent consultants to Murchison and the Brabant-McKenzie project.

About Murchison Minerals Ltd. (TSXV: MUR)

Murchison is a Canadian‐based exploration company focused on the exploration and development of the 100% owned Brabant‐McKenzie zinc‐copper‐silver project in north‐central Saskatchewan. The Company also has a 100% interest in the HPM nickel‐copper‐cobalt project in Quebec. Murchison has 78.7 million shares issued and outstanding.

Additional information about Murchison and its exploration projects can be found on the Company's website at www.murchisonminerals.com. For further information, please contact:

Jean‐Charles (JC) Potvin, President and CEO
jcpotvin@murchisonminerals.com

Erik H Martin, CFO
Tel: (416) 350‐3776
info@murchisonminerals.com

Cathy Hume, CHF Capital Markets
Tel: (416) 868-1079 x 251
cathy@chfir.com

Twitter: @MurchisonMiner
Facebook: Murchison Minerals
LinkedIn: Murchison Minerals

Forward‐Looking Information

Certain information set forth in this news release may contain forward‐looking information that involves substantial known and unknown risks and uncertainties. This forward‐looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, the impact of general economic conditions, industry conditions, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward‐looking information. The parties undertake no obligation to update forward‐looking information except as otherwise may be required by applicable securities law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Murchison Minerals Ltd.

ReleaseID: 602393

VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Omni Commerce Corp. ("Omni" or the "Company") is pleased to announce that, further to its news releases dated April 27, 2020 and June 1, 2020, it has completed the acquisition of CBLT Inc.'s (TSXV:CBLT) ("CBLT") 56% majority joint venture interest in the Northshore Gold Property (the "Property"), located in the Schreiber-Hemlo Greenstone Belt, 115 km west of Hemlo and 200 km east of Thunder Bay.

John Veltheer, the CEO and a director of Omni, commented, "We are very pleased to be closing this acquisition as the first step to reunifying the Northshore property and then exploring the property in order to delineate a mineral resource estimate."

Summary of the Transaction

Pursuant to the terms and conditions of a mineral property purchase and sale agreement (the "Agreement") dated May 29, 2020 with CBLT, the Company acquired the 56% joint venture interest in the Property for total aggregate consideration of $1,450,000 (collectively, the "Purchase Price"), consisting of: (i) cash consideration of $350,000 (the "Cash Consideration") and (ii) stock consideration of $1,100,000 payable by the issuance the issuance of an aggregate of 9,166,666 common shares in the capital of the Company (each, a "Consideration Share") at a deemed price of $0.12 per Consideration Share. All of the Consideration Shares are subject to the terms of a voluntary escrow agreement dated August 18, 2020, which terms include the release of 25% of the Consideration Shares from escrow on each of the days which is four, six, eight and 12 months after the closing of the transactions contemplated by the Agreement (the "Closing"). The voluntary escrow will be in addition to and any resale restrictions imposed under applicable securities laws.

In connection with the Transaction, the Company issued 362,500 common shares of the Company at a deemed price of $0.12 per share to an arm's length finder. The finder's shares are subject to a hold period expiring four months and one day from Closing. CBLT intends to pay two additional arm's length finders in connection with the Transaction, which finder's fees will be paid by CBLT directly and will be comprised of an aggregate cash finder's fee of $15,000 and an aggregate of 458,333 common shares of the Company which will be transferred to such finder's by CBLT from the Consideration Shares, from time to time, as they are released from escrow.

Corporate Updates

The Company has submitted an application to the Canadian Stock Exchange for the listing of its common shares. This is a key step in the relisting of the Company's shares on a recognized stock exchange.

Following the completion of the transaction with CBLT, the Company intends to proceed with its previously announced consolidation of its outstanding securities on the basis of five (5) pre-consolidation common shares of the Company for one (1) post-consolidation common share of the Company (the "Consolidation").

The Company also intends to proceed with completion of the acquisition of the remaining 44% interest in the Property from Balmoral Resources Ltd. on or before August 31, 2020.

For more information on the Property and the Consolidation, see the Company's news releases dated April 27, 2020 and June 1, 2020 filed under the Company's profile on SEDAR at www.sedar.com.

The Company also entered into a mineral property purchase agreement dated August 14, 2020 with Trillium Mining Corp. ("Trillium") for the purchase of 11 unpatented mineral claims comprising an aggregate of 233.963 hectares situated in the Schreiber Area of the Thunder Bay Mining Division, Ontario (the "Schreiber Claims"). The Schreiber Claims are adjacent to the Northshore Gold Property and connect the two parts of the Property. The Company paid $25,000 cash to Trillium in consideration for transfer of the Schreiber Claims.

About Omni

Omni is headquartered in Vancouver, British Columbia and is a reporting issuer in British Columbia and Alberta.

ON BEHALF OF THE BOARD

OMNI COMMERCE CORP.

Per: "John Veltheer"
John Veltheer, CEO

For further information, please contact:

John Veltheer
Phone: (604) 562-6915
Email: john@veltheer.com
Website: www.omnireset.com

Forward-Looking Statements:

This news release contains forward-looking statements and forward-looking information (collectively, "forward looking statements") within the meaning of applicable Canadian legislation. Forward-looking statements are typically identified by words such as: "believes", "expects", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Accordingly, all statements in this news release that are not purely factual or historical in nature are forward-looking statements and include statements regarding beliefs, plans, expectations and orientations regarding the future. Forward looking statements in this news release include statements that the Company will complete the Consolidation and the transaction with Balmoral Resources Ltd., the timing for completion of these transactions and the resale restrictions on the shares issued in connection with the CBLT transaction. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information. Further, the novel coronavirus and the COVID-19 pandemic pose new risks that are currently indescribable and immeasurable. Other factors may also adversely affect the future results or performance of the Company, including general economic, market or business conditions, future prices of cannabis, changes in the financial markets and in the demand for cannabis, changes in laws, regulations and policies affecting the cannabis industry, risks related to the acquisition of the interest in the Property and the Company's investment and operation in the mineral exploration sector in Northern Ontario, as well as the risks and uncertainties which are more fully described in the Company's annual and quarterly management's discussion and analysis and in other filings made by the Company with Canadian securities regulatory authorities under the Company's profile at www.sedar.com. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.

These forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements.

SOURCE: Omni Commerce Corp.

ReleaseID: 602365

Largest Quarterly Revenues and Gross Profit in Company's History

VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) ("Organto" or "the Company"), an integrated provider of fresh organic fruits and vegetables today announced financial results for the second quarter ended June 30, 2020. All amounts are expressed in Canadian dollars and results are reported in accordance with International Financial Reporting Standards (IFRS), except where specifically noted.

Highlights:

Second quarter revenues of $2,163,955, an increase of approximately 3,350% versus the same quarter in the prior year. Second quarter revenues represent the largest quarterly revenues in the history of Organto.

Year-to-date revenues of $3,773,775, an increase of approximately 1,850% versus the same period in the prior year. Revenues for the first six months of fiscal 2020 exceed revenues for the full twelve months of fiscal 2019.

Gross profit of $232,504 or 10.7% of revenues, an increase of approximately 2,700% versus the same quarter in the prior year, and the largest quarterly gross profit in the history of Organto.

YTD gross profit of $392,981 or 10.4% of revenues, versus negative gross profits of ($22,866) for the same period in the prior year.

Overhead costs in the second quarter, including certain costs related to financings completed during the quarter, reduced to 29.8% of revenues versus 36.4% in the first quarter of 2020 and over 100% in the prior year.

Balance sheet strengthened with cash position of $1,577,017 and working capital deficit improved versus Q-1 2020 by $3,131,759.

"Our second quarter results represent our fourth consecutive quarter of record revenues and the largest revenue and gross profit quarter in our history. We are pleased with our progress, and when combined with our recently completed oversubscribed financings, we believe we are well positioned for exciting growth." commented Steve Bromley, Chair and Interim CEO of Organto. "Demand for fresh organic fruits and vegetables continues to grow, driven by increased consumer interest in healthy foods that are produced in a sustainable and transparent manner. We believe our cost-effective and flexible business model has proven its value and that we are well positioned to benefit from market demand. The funds raised from our recently closed financings will be used to expand our supply and range of product offerings and accelerate our growth, enabling our business to ramp up to an annualized revenue run rate of CDN $20 million and achieving cash-flow breakeven by year-end, both key milestones in our strategic plan."

Second Quarter Results

Revenues for the second quarter were a record $2,163,955, an increase of approximately 3,350% versus the same quarter in the prior year. Second quarter revenues were the largest quarterly revenues in the Company's history, driven sales of organic and non-GMO avocado, asparagus, ginger and a range of soft fruits.

Gross profit was $232,504 or 10.7% of revenues, also a record and the largest quarterly gross profit in the Company's history, versus gross profit of $8,265 in the prior year.

Selling, general and administrative expenses in the quarter were $188,822 versus $229,231 in the prior year, a decrease of 17.7%, due to primarily to streamlined administration processes and reduced professional fees. Included in current quarter costs are approximately $25,000 related to the convertible note and equity financings which were completed during the quarter. Management fees in the quarter were $158,441 versus $159,058 in the prior year, while salaries and benefits in the quarter were $232,013 versus $109,208 in the prior year. The increase in salaries and benefits was as expected, driven by incremental commercial and administrative resources required to both support growth realized to date and position the business for continued future growth. Non-cash stock-based compensation was $65,21 in the quarter versus $67,526 in the prior year.

Loss from continuing operations in the second quarter was $355,724 or $0.00 per common share versus a loss of $556,381 or $0.00 per common share in the prior year. Net loss for the second quarter was $355,724 versus net income of $743,974 in the prior year. During the second quarter of 2019 the Company realized a gain from discontinued operations of $1,300,355 representing the sale of the Company's medicinal cannabis operations.

At June 30, 2020, Organto's balance sheet reflected total assets of $4,468,718 including cash of $1,577,017. Included in liabilities is short-term loans payable of $704,946 and non-current debt of $2,007,500.

Interested parties may access the Company's filings at www.SEDAR.com or at the Company's website at www.organto.com under the Investors tab.

Extension of Bridge Loans

On April 28, 2020 the Company announced that it had reached an agreement with a former executive and director (the "Bridge Lender") of the Company to extend certain bridge loans originally made in 2018, and to grant 1.5 million warrants to the Bridge Lender at a strike price of C$0.065 per share for a period of 18 months subject to TSX regulations. The Company has received TSX Venture Exchange acceptance and the warrants have been issued. As per TSX Venture Exchange policy 5.1, the expiry date for a pro-rata portion of the warrants will be accelerated for any loan payments made between May 2020 and May 2021.

Stock Option Grants

Organto also announced that it has granted 750,000 stock options to employees as per the terms of the Company's Share Option Plan. These options have an exercise price of CDN $0.10 with a term of five years, with 20% vesting immediately and 20% on each anniversary thereafter.

Shares for Debt Settlement

Organto also announced that it has entered into an agreement with a service provider to convert CDN $69,795.50 of amounts due into common shares of the Company at a price of CDN $0.10 per share, subject to TSX Venture Exchange acceptance.

ON BEHALF OF THE BOARD,

Steve Bromley
Chair and Interim Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information contact:

Investor Relations
604-634-0970
1-888-818-1364
info@organto.com

ABOUT ORGANTO

Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people and its shareholders. Organto is an integrated provider of private label and bulk distributed organic and non-GMO fruit and vegetable products using an asset-light business model to serve a growing socially responsible and health conscious consumer around the globe.

FORWARD LOOKING STATEMENTS

This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's business model and markets; Organto's belief based on progress in the business and recently completed financings, that the business is well positioned for exciting growth; Organto's belief demand for fresh organic fruits and vegetables continues to grow; Organto's belief that their cost-effective and flexible business model has proven its value; Organto's belief that it will be able to ramp-up to an annualized revenue run rate of $20 million and cash-flow breakeven by the end of 2020; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented and product supply will be increased; cost increases; dependence on suppliers, partners and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws and similar risks; transportation costs and risks; general business and economic conditions; and ongoing relations with distributors, customers, employees, suppliers, consultants, contractors and partners. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.

SOURCE: Organto Foods Inc.

ReleaseID: 602350

Kontrol BioCloud®

TORONTO, ON / ACCESSWIRE / August 19, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") is pleased to provide an update on the timing of the next stage of testing for the Kontrol BioCloud® analyzer ("BioCloud").

For more than a decade, through its operating subsidiaries, Kontrol has been providing air quality testing and continuous emission monitoring across hundreds of industrial facilities in Canada and the USA. BioCloud represents an extension and further innovation of an existing air quality technology and solution platform which Kontrol currently provides to its customers.

"We are drawing on our extensive experience in air quality and emission monitoring for specific particulate analysis and measurement and using similar technology to detect for COVID-19 in the air," says Paul Ghezzi, CEO of Kontrol. "Over the past 6 months, we have secured government funding, established partnerships with virology experts, and developed a proprietary COVID-19 detection chamber. Our initial lab results and interest from potential customers and prospects give us the confidence that we are developing a solution which the market demands. We look forward to providing more details as we continue BioCloud's development."

Next Stage of Testing

Live COVID-19 virus testing will commence on August 19th, 2020 and is expected to continue until the end of the month. The testing will focus on the capability of the working BioCloud prototype to sample the COVID-19 virus in aerosol form and seek to establish the lower detection limits that can be achieved. Kontrol will publish the results following the testing.

Detection Mechanism

Kontrol has designed BioCloud with a replaceable detection mechanism. Kontrol will seek to patent the detection mechanism following the next stage of testing. Kontrol will also analyze the best method of replacing and disposing of the detection mechanism after it comes into contact with COVID-19. The detection mechanism has been built to be an ongoing replaceable component of the BioCloud technology.

"BioCloud will seek to sample the air over-time on a continuous basis, which is similar to how we currently test for air quality in industrial facilities. Applications for BioCloud will be focused initially on classrooms, hospitals, long-term care homes, and mass transportation." said Gary Saunders, Kontrol's Vice President.

Pre-Commercialization Prototypes

Kontrol has built one operating prototype and is in the process of completing four additional pre-commercialization prototypes. These prototypes will be made available for lab testing and also provide Kontrol with greater certainty for developing its supply chain for parts and materials for potential future commercialization. The additional four prototypes will be completed prior to August 31st, 2020.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

About Kontrol Energy

Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.

For further information, contact:

Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com or admin@kontrolenergy.com
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company's product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol's lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

ReleaseID: 602360

VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Stillcanna Inc. (OTC PINK:SCNNF) (CSE:STIL) (FRANKFURT:A2PEWA) ("STIL" or the "Company"), is pleased to announce that the shareholders of Sativa Group PLC, one of the United Kingdom's (UK) first medical Cannabis Companies, have overwhelmingly voted in favour of the acquisition.

On August 27, 2020 Stillcanna is holding a special meeting of its shareholder to vote on the Sativa Group acquisition. It is anticipated that Stillcanna shares will resume trading the first week of September.

The details of the acquisition where previously announced on June 3, 2020. Stillcanna will continue to trade, or otherwise be quoted on the CSE, OTC and FSE following completion of the acquisition. Stillcanna intends to list the Stillcanna shares on the AQSE on or shortly after the effective date in order to maintain access to the AQSE for shareholders of the combined group. This is subject to Stillcanna completing the relevant admission process with the AQSE.

"I am delighted the Sativa shareholders have so fully embraced our proposed acquisition of the Sativa Group of Companies," stated Jason Dussault CEO of Stillcanna. We are fast approaching the final stages of this acquisition and the entire Stillcanna team looks forward to monetizing on the combined strengths of the new entity."

As previously announced on April 21, 2020 all required licenses and permits to commence the manufacturing of CBD at the ORIGIN extraction facility have been secured. The facility was constructed through a joint venture partnership with Dragonfly Biosciences Limited of the UK. Borganic Consulting had initiated legal action in the UK against Dragonfly Biosciences for contractual breaches under the partnership agreement.

Further to the announcement on April 21, 2020 Stillcanna Inc.'s subsidiary Borganic Consulting Inc. ("Borganic") has, with immediate effect today, terminated its Joint Venture agreement dated December 4, 2018 with Dragonfly Biosciences Limited ("Dragonfly").

The termination includes a claim for Dragonfly's share of the Joint Venture extraction facility.

Proceedings issued in the English High Court have also been served by Borganic today on Dragonfly and also on Ms Radostina Draganova-Nikolova, a director of Dragonfly and general manager of the Joint Venture company.

In the proceedings served by Borganic it seeks declarations from the English High Court that:

Dragonfly has materially and persistently breached the Joint Venture agreement which constitutes a compulsory transfer event in favour of Borganic;
The notice of termination and compulsory transfer event served by Dragonfly on August 3, 2020 is null and void; and
Borganic retains ownership in the equipment it has financed at the Joint Venture extraction facility.

Borganic also claims damages against Dragonfly for the losses it has suffered as a result of Dragonfly's alleged breaches of the Joint Venture agreement.

About Sativa Group PLC

The Sativa Group PLC joined the UK's NEX market in March 2018 as the UK's first medicinal cannabis investment vehicle.

The business evolved to focus on the development of an operational business capitalizing on its first-mover advantage. This change transitioned the Company from an investment Company to an operating Company at the forefront of both the CBD wellness and medicinal cannabis sectors in the UK.

About Stillcanna Inc.

Stillcanna Inc. (CSE: STIL) www.stillcanna.com is a Canadian early-stage life sciences Company focused on the large scale manufacturing of CBD in Europe. The Company believes its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences LLC, a United Kingdom-based supplier of CBD. The Company also recently completed the of Olimax NT SP. Z .O.O, a multi-generational hemp agricultural firm that is expected to increase the Company's market share in the European CBD industry.

On Behalf of the Board

Jason Dussault, CEO

CONTACT:

inquiries@stillcanna.com

Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release.

This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Stillcanna's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved".

The forward-looking information and forward-looking statements contained herein include, but are not limited to information concerning the Proposed Transaction or the approval of the Proposed Transaction by the Stillcanna shareholders and certain shareholder and regulatory requirements. Although Stillcanna believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements.

In particular, there is no guarantee that that the parties will successfully complete the Proposed Transaction on the terms contemplated herein or that all required shareholder or regulatory approvals will be obtained. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Stillcanna does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

SOURCE: Stillcanna Inc.

ReleaseID: 602391

The Collaboration Expands the Availability of High Quality, Validated Data from Various Data Suppliers on AWS Data Exchange

NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Cloud-based data delivery and operations platform, Crux Informatics ("Crux"), today announced a strategic collaboration with Amazon Web Services (AWS). Under the collaboration, Crux's data validation and operations infrastructure will be used to scale onboarding process for data providers and ongoing management of data on AWS Data Exchange.

"The engagement enables customers of AWS Data Exchange to immediately benefit from the infrastructure, operational services and data supplier partnerships we've built," said Philip Brittan, CEO of Crux Informatics. "Customers now have access to more data from our world-class platform that enables automated ingestion, validation and delivery of thousands of datasets, in almost any format, from hundreds of sources. We maintain the pipelines so data suppliers who are integrated with Crux can automatically deliver their data via AWS Data Exchange to AWS customers, enhancing the experience of working with data in AWS."

Crux manages data operations among a vast network of over 100 traditional, alternative and public data suppliers, facilitating faster and easier data delivery to financial services organizations and investment teams. This collaboration provides an easy step for data providers to quickly access the growing consumer audience on AWS Data Exchange. Crux will onboard data providers and build pipelines into AWS Data Exchange, providing a turnkey solution to suppliers and consumers alike. In addition, Crux can ingest data in almost any file format and from nearly any destination, making a frictionless experience that plugs directly into a data provider's workstream.

"Our strategic collaboration with Crux addresses our customers' need for diverse, high-quality and well-curated data on AWS Data Exchange," said Samantha Gibson, Global Lead for Financial Services, AWS Data Exchange, at Amazon Web Services. "Crux focuses on data quality and reliability while providing data that is ready for use with AWS services. By taking care of onboarding, validation and reliable operation of data products, Crux allows our data providers to accelerate distribution and scale operational efficiency. AWS customers will also benefit from well-defined metadata and operational data, enabling them to accelerate their understanding and use of various datasets."

AWS Data Exchange makes it easy for customers to find, subscribe to and use third-party data in the cloud to gain insights that run their businesses. Crux's platform is designed to streamline the building of data pipelines, the ongoing validation of data quality and management of the operations between suppliers and consumers at scale.

Learn more about the Crux datasets on AWS Data Exchange here.

# # #

About Crux

Crux helps companies reliably get the data they need, how they need it and where they need it. Our data delivery and operations platform and managed service ensures that data flows seamlessly between data suppliers and data consumers. By working directly with suppliers and serving many consumers, Crux unlocks economies of scale that benefit the entire industry. We deliver data at a lower cost, via flexible delivery methods, and at a consistently high-level of service and security. Learn more at Cruxinformatics.com.

CONTACT:

Contact: Stephen Sumner
Caliber Corporate Advisers
Email-Address: stephen@calibercorporateadvisers.com
Phone: 917.985.6630 ext.15

SOURCE: Crux Informatics

ReleaseID: 602320

BOSTON, MA / ACCESSWIRE / August 19, 2020 / AG Mednet, a technology company streamlining, automating and increasing data quality for clinical trials, has named Brian Zabin as COO. In his new position, Zabin will help continue AG Mednet's strong momentum in furthering clinical trial workflow and automation through adoption of Judi, the company's clinical trial technology platform. He will play a crucial role in driving key operational and financial performance measures while advancing the company's long-term strategy by developing new areas for growth, pursuing key strategic partnerships and leading AG Mednet's drive to develop solutions for unmet areas of data quality needs and workflow inefficiencies in the industry.

Zabin is a returning member of AG Mednet's original team, having served as Vice President, Business Development from 2007 to 2009. At that time, Zabin led the implementation of the company's strategy and investment in the clinical trials market.

Zabin, an MIT Sloan School of Management graduate, most recently served as a diplomat in various countries for the U.S. Department of State, worked for Boston Consulting Group in the Health Care practice in Boston and Zurich, and is a former Captain in the United States Marine Corps.

"AG Mednet is on an industry-wide rapid growth trajectory, and that path is accelerating across all facets of the clinical trials industry," said Abraham Gutman, founder and CEO of AG Mednet. "For the past 25 years, Brian has served in various leadership positions across the military, business and international trade and diplomacy. There is no one more capable of working with me and leading AG Mednet's strategic growth than Brian."

About AG Mednet

AG Mednet is the leading quality compliance partner for image data management, DSMB, endpoint and adverse event adjudication workflows. The company is a proponent of zero-delay clinical trials. The company has supported more than 1,800 global clinical trials. Hundreds of adjudication protocols are being managed by sponsors and CROs using Judi. More than 70,000 registered users across thousands of investigator sites in more than 80 countries use AG Mednet to submit more than 20,000,000 images per month and adjudicate thousands of events in projects sponsored by each of the world's top 20 pharmaceutical, biotech and medical device companies. Learn more at www.agmednet.com.

CONTACT:

Olivia Martin
781.353.7002
omartin@mower.com

SOURCE: AG Mednet

ReleaseID: 602321

Diversity- and inclusion-driven fund to begin trading at the onset of LGBT History Month

LEVITTOWN, PA / ACCESSWIRE / August 19, 2020 / ProcureAM, a wholly owned subsidiary of Procure Holdings, LLC, intends to launch the LGBTQ+ ESG100 ETF (Ticker:LGBT) on Oct. 1, 2020, in partnership with LGBTQ Loyalty Holdings, Inc. (LGBTQ Loyalty) and its wholly owned subsidiary Advancing Equality Preference, Inc.

LGBT will trade on the Nasdaq and track the LGBTQ100 ESG Index (Index Ticker:LGBTQ100), which identifies the top 100 corporations that most align with the LGBTQ community across America. It is the first-ever index to incorporate LGBTQ community survey data into the methodology, generating a benchmark of the nation's highest-performing companies that are most committed to advancing equality. The Index outperformed the market for the first half of the year (Jan. 1-June 30, 2020), exceeding the S&P 500 Index benchmark by 3.41%.

"Pressing corporations to implement diversity and ensure that their practices represent a commitment to LGBTQ equality is important," said Barney Frank, former U.S. Congressman and LGBTQ Loyalty board member. "So is providing a positive incentive. Giving the LGBTQ community, and our friends and allies, a way to do this through their investments is the best example of this approach. I am proud to be a part of this effort, which brings together two of the major themes of my work in Congress: a financial system that serves both private and public needs, and human rights," added Frank.

LGBT will be the inaugural ETF launched via the Procure Asset Launchpad (PAL), ProcureAM's partnered platform.

"With a combined two decades of experience working with third-party ETF platforms, we have developed a unique partnership model to improve upon the options currently available in the marketplace," said Andrew Chanin, CEO of ProcureAM. "We couldn't think of a better partner than LGBTQ Loyalty and its prestigious board of directors to launch this arm of our business with, and we look forward to continuing to expand our platform to help reshape the exchange-traded product landscape."

Other distinguished members of the LGBTQ Loyalty Board of Directors include Major League Baseball Vice President and Special Assistant to the Commissioner, Billy Bean; International Tennis Hall of Famer, Martina Navratilova; LGBTQ media entrepreneur and former world-ranked tennis professional, Bobby Blair; and former CEO of Pride Media, Orlando Reece.

For additional information on ProcureAM and its ETF platform, please visit www.ProcureETFs.com.

About ProcureAM
ProcureAM, LLC (ProcureAM) is an innovative exchange-traded product (ETP) issuer based in Levittown, Pennsylvania. Established by renowned industry veterans Robert Tull and Andrew Chanin, ProcureAM offers a unique platform for the creation of both proprietary and partnered ETPs. ProcureAM listens to clients and endeavors to provide investors with access to distinct investment opportunities. Whether you are looking to invest in ETPs or create one, contact ProcureAM to explore your performance potential: www.ProcureETFs.com.

About LGBTQ Loyalty Holdings, Inc.
LGBTQ Loyalty is a diversity- and inclusion-driven financial methodology and data company that quantifies corporate equality alignment with the LGBTQ community and minority interest groups. The Company has benchmarked the first-ever U.S. Loyalty Preference Index, which the Company believes empowers the LGBTQ community to express their preferences for the nation's high-performing corporations most dedicated to advancing equality. The Loyalty Preference Index, branded as the LGBTQ100 ESG Index, is an environmental, social and governance (ESG) Index, offering an added perspective for those seeking to align with equality-driven, ESG-responsible corporations. LGBTQ Loyalty's leadership includes seasoned authorities in the financial industry and the LGBTQ community. www.lgbtqloyalty.com

Media contacts:
Gregory FCA for ProcureAM
Rachelle Gaynor, 631-278-2046
procuream@gregoryfca.com

LGBTQ Loyalty Holdings, Inc.
press@lgbtql.com
1-310-870-9661

The LGBTQ100 ESG index tracks equality-driven U.S. companies from a universe of 500 publicly traded large-cap corporations. The companies are also screened to insure they meet the index provider's methodology ESG compliance, by a world leading provider of corporate governance and responsible investment. It is not possible to invest directly in an index.

The S&P 500 Index measures the performance of the large-cap segment of the U.S. equity market. The index is composed of 500 large-cap constituent companies listed on stock exchanges in the United States.

Please consider the Fund's investment objectives, risks, and charges and expenses carefully before you invest. This and other important information is contained in the Fund's summary prospectus and prospectus, which can be obtained by visiting www.PALETFs.com or call 1-866-690-3837. Read carefully before you invest.

Investing involves Risk. Principal loss is possible. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV and are not individually redeemed from the funds. Brokerage commissions will reduce returns. Additional Fund risks include: Technology Sector Risk, Healthcare Sector Risk, Finance Sector Risk, Concentration Risk, Cyber Security Risk, and Liquidity Risk. For additional information please see the prospectus.

Distributed by Quasar Distributors LLC

SOURCE: ProcureAM

ReleaseID: 602335